2019
DOI: 10.1016/j.jfma.2019.02.007
|View full text |Cite
|
Sign up to set email alerts
|

Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unit

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 35 publications
0
4
0
Order By: Relevance
“…Physicians may be hesitant to put cancer patients in mechanical ventilation or NIV as studies have demonstrated cancer patients were more likely to have slower recovery and more difficult to wean. 28,29 The underlying stages of malignancies and status of do-not-resuscitation order were not recorded in the present cohort. Despite this, vasopressors and a short trial of NIV were the routine first-line treatments in our center.…”
Section: Discussionmentioning
confidence: 89%
See 1 more Smart Citation
“…Physicians may be hesitant to put cancer patients in mechanical ventilation or NIV as studies have demonstrated cancer patients were more likely to have slower recovery and more difficult to wean. 28,29 The underlying stages of malignancies and status of do-not-resuscitation order were not recorded in the present cohort. Despite this, vasopressors and a short trial of NIV were the routine first-line treatments in our center.…”
Section: Discussionmentioning
confidence: 89%
“…Patients with malignancy received less invasive mechanical ventilation (35.7% vs. 45.9%, p = 0.018). Physicians may be hesitant to put cancer patients in mechanical ventilation or NIV as studies have demonstrated cancer patients were more likely to have slower recovery and more difficult to wean 28,29 . The underlying stages of malignancies and status of do‐not‐resuscitation order were not recorded in the present cohort.…”
Section: Discussionmentioning
confidence: 95%
“…The presence of underlying active cancer and metastatic status are both important predictors for in-hospital mortality due to their immune-compromised status [14]. The effect of cancer on a patient's outcome has been proven in critical care [15,16]. However, whether patients have cancer with or without metastasis may provide little insight on the poor prognosis, and as high as 25% of terminal cancer patients receive vasopressors in the dying process [17].…”
Section: Discussionmentioning
confidence: 99%
“…In patients with MV support, we found that noncancer patients had survive advantage at the point of 28-day and 90-day after ICU admission. Hsiue et al [25]compared 518 patients with solid cancers with 1362 non-cancer patients receiving MV admitted to ICU between 2012 and 2014. They found that the 28-day and 90-day mortality rates were higher in cancer patients than in noncancer patients (45.2% vs. 29.4%, and 65.6% vs. 37.7%, respectively, both P < 0.001).…”
Section: Discussionmentioning
confidence: 99%